Where does Sir Steve Jackson work?

Sir Steve Jackson is Founding Partner at Ahren Innovation Capital.

Where did Sir Steve Jackson go to school?

Sir Steve Jackson studied at University of California, Berkeley; The University of Edinburgh (Doctor of Philosophy - PhD, Cell/Cellular and Molecular Biology); University of Leeds (BSc Hons).

Sir Steve Jackson

Investor

Founding Partner at Ahren Innovation Capital

Minnetonka, Minnesota, United States

About

Sir Steve Jackson originated olaparib/Lynparza—the first marketed DNA-repair enzyme inhibitor, partnered with AstraZeneca and Merck—and combines a Cambridge professorship with part‑time CEO and early-stage operating experience.

Invests in

AI & Machine LearningBiotechClimate TechDeep TechHardwareRobotics

Experience

Insmed Innovation UKChief Research Officercurrent2023 — presentBabraham Research Campus, UK
Ahren Innovation CapitalFounding Partnercurrent2018 — present
Mission Therapeutics Ltd.Founding Scientistcurrent2011 — present
University of CambridgeProfessor of Biology (Frederick James Quick Professor)current1995 — present
Adrestia Therapeutics Ltd.Founder and Chief Scientific Officer2018 — 2023Cambridge, United Kingdom
The Gurdon Insititute, University of CambridgeHead of Cancer Research UK Laboratories2004 — 2022
The Gurdon Institute, University of CambridgeGroup Leader1991 — 2022
Mission TherapeuticsFounder and Chief Scientific Officer2010 — 2017
KuDOS PharmaceuticalsFounder and Chief Scientific Officer1997 — 2006Cambridge, UK

Colleagues at Ahren Innovation Capital

Alice Newcombe-Ellis

Founding and General Partner at Ahren Innovation Capital

Andy Parker

Founding Partner at Ahren Innovation Capital

Anuj Nanwani

Principal at Ahren Innovation Capital

David Novak

Advisor at Ahren Innovation Capital

Diego Alegría

Investment Analyst at Wollef Ventures

Eve Young

Head of Corporate Affairs and Branding at Tetragon Financial Group Limited

Jaime Díaz Torre

Associate at Glisco Partners

Janusz Marecki

AI Partner at Ahren Innovation Capital

Frequently asked questions

Who is Sir Steve Jackson?: Sir Steve Jackson originated olaparib/Lynparza—the first marketed DNA-repair enzyme inhibitor, partnered with AstraZeneca and Merck—and combines a Cambridge professorship with part‑time CEO and early-stage operating experience.
Where does Sir Steve Jackson work?: Sir Steve Jackson is Founding Partner at Ahren Innovation Capital.
What does Sir Steve Jackson invest in?: Sir Steve Jackson invests in AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Robotics.
Where did Sir Steve Jackson go to school?: Sir Steve Jackson studied at University of California, Berkeley; The University of Edinburgh (Doctor of Philosophy - PhD, Cell/Cellular and Molecular Biology); University of Leeds (BSc Hons).

Same school

Also attended University of California, Berkeley1,624

Byron DeeterPartner at Bessemer Venture Partners Steve WozniakCo-founder of Apple Tony XuCo-founder & CEO of DoorDash Ali GhodsiCo-founder & CEO of Databricks Ryan PetersenFounder & CEO of Flexport Dave JohnsonCo-founder & CEO of Dash Bio

+ 1,618 more

Also attended The University of Edinburgh294

Abraham BachrachCo-founder & CTO of Skydio Sofia DolfeInvestor at Index Ventures Freya Svedberg-KeatingInvestor at Medicxi Kevin JohnsonInvestor at Medicxi Patrick NorrisGeneral Partner at Notion Capital Sarah MandersonLegal Director at Hoxton Ventures

+ 288 more

Also attended University of Leeds164

Joseph StolermanInvestor at Index Ventures Laura CliffordTalent Director at Northzone David CarterPartner, Engineering Excellence at Sapphire Ventures Ian MilbournGeneral Partner & COO at Notion Capital John MesrieOperating Partner at Inreach Ventures Paul “JF” ZohorskyManaging Partner at ZEA

+ 158 more

Shared employers

Also worked at University of Cambridge184

Masha LevinVenture Partner at One Way Ventures Chris WeyrerPrincipal at Vida Ventures Alex LoftisPrincipal at Vida Ventures Annie DongInvestor at Dorm Room Kaitlyn KeatonSenior Software Engineer at Red Cell Incubation Francesco PomponiInvestor at Extantia Capital

+ 178 more

Also worked at Mission Therapeutics8

Jonathan HeppleManaging Partner at Rosetta Capital Ltd.Louis BlanchardAnalyst at Sodero Deborah HarlandChair, LifeArc Ventures Investment Committee at LifeArc Ventures Anne PhelanDDF SAB Member at Dementia Discovery Fund Zoé TournilhacAssociate at MBO+Eve YoungHead of Corporate Affairs and Branding at Tetragon Financial Group Limited

+ 2 more

Also worked at KuDOS Pharmaceuticals3

Eve YoungHead of Corporate Affairs and Branding at Tetragon Financial Group Limited Steve JacksonPartner at Ahren Innovation Capital Lana DweikInvestor at Altaris Capital Partners